A carregar...
Ursodeoxycholic acid for primary biliary cirrhosis
BACKGROUND: Ursodeoxycholic acid is administered to patients with primary biliary cirrhosis, a chronic progressive inflammatory autoimmune‐mediated liver disease with unknown aetiology. Despite its controversial effects, the U.S. Food and Drug Administration has approved its usage for primary biliar...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2012
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045744/ https://ncbi.nlm.nih.gov/pubmed/23235576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000551.pub3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|